Measles poses significant threats to public health and to vulnerable populations, including young children, elderly individuals, and those with weakened immune systems. IDSA recommends strong immunization requirements regarding all CDC-approved vaccines with exemptions provided only in cases of medical contraindication.
Patient Information
IDSA Statements
- IDSA Statement on WHO/CDC Global Measles Report
- Infectious Diseases Society of America’s Policy on State Immunization Mandates
- IDSA Policy Recommendations
Measles Related CDC Alerts
Journal Articles
- Early measles vaccination during an outbreak in The Netherlands: reduced short and long-term antibody responses in children vaccinated before 12 months of age, JID - April 11, 2019
- Principal Controversies in Vaccine Safety in the United States, CID - Feb. 12, 2019
- Sero-prevalence surveillance to predict vaccine-preventable disease outbreaks; a lesson from the 2014 measles epidemic in northern Vietnam, OFID - Jan. 24, 2019
- Eradicating measles - a call for an exceptional coordinated global effort, JID - Jan. 7, 2019
- International Importations of Measles Virus into the United States During the Postelimination Era, 2001–2016, JID - Dec. 2018
- Health Care–Associated Measles Outbreak in the United States After an Importation: Challenges and Economic Impact, JID - June 2011
- Measles Collection
- Vaccines Virtual Collection